Literature DB >> 22941935

Beta-catenin-NF-κB interactions in murine hepatocytes: a complex to die for.

Kari Nejak-Bowen1, Alexander Kikuchi, Satdarshan P S Monga.   

Abstract

UNLABELLED: Wnt/β-catenin signaling plays an important role in hepatic homeostasis, especially in liver development, regeneration, and cancer, and loss of β-catenin signaling is often associated with increased apoptosis. To elucidate how β-catenin may be regulating hepatocyte survival, we investigated the susceptibility of β-catenin conditional knockout (KO) mice and their wild-type (WT) littermates to Fas and tumor necrosis factor-α (TNF-α), two common pathways of hepatocyte apoptosis. While comparable detrimental effects from Fas activation were observed in WT and KO, a paradoxical survival benefit was observed in KO mice challenged with D-galactosamine/lipopolysaccharide. KO mice showed significantly lower morbidity and liver injury due to early, robust, and protracted activation of NF-κB in the absence of β-catenin. Enhanced NF-κB activation in KO mice was associated with increased basal inflammation and Toll-like receptor 4 expression and lack of the p65/β-catenin complex in hepatocytes. The p65/β-catenin complex in WT livers underwent temporal dissociation allowing for NF-κB activation to regulate hepatocyte survival following TNF-α-induced hepatic injury. Decrease of total β-catenin protein but not its inactivation induced p65 activity, whereas β-catenin stabilization either chemically or due to mutations repressed it in hepatomas in a dose-dependent manner, whereas β-catenin stabilization repressed it either chemically or due to mutations.
CONCLUSION: The p65/β-catenin complex in hepatocytes undergoes dynamic changes during TNF-α-induced hepatic injury and plays a critical role in NF-κB activation and cell survival. Modulation of β-catenin levels is a unique mode of regulating NF-κB activity and thus may present novel opportunities in devising therapeutics in specific hepatic injuries.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22941935      PMCID: PMC3566301          DOI: 10.1002/hep.26042

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

Review 1.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

Authors:  Xue Wang; Marie C DeFrances; Yu Dai; Peter Pediaditakis; Carla Johnson; Aaron Bell; George K Michalopoulos; Reza Zarnegar
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

3.  NFkappaB and caspase-3 activity in apoptotic hepatocytes of galactosamine-sensitized mice treated with TNFalpha.

Authors:  Dan Tapalaga; Gisa Tiegs; Sabine Angermüller
Journal:  J Histochem Cytochem       Date:  2002-12       Impact factor: 2.479

4.  Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand.

Authors:  M D Josephs; F R Bahjat; K Fukuzuka; R Ksontini; C C Solorzano; C K Edwards; C L Tannahill; S L MacKay; E M Copeland; L L Moldawer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-05       Impact factor: 3.619

5.  Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation.

Authors:  T S Blackwell; F E Yull; C L Chen; A Venkatakrishnan; T R Blackwell; D J Hicks; L H Lancaster; J W Christman; L D Kerr
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

6.  Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.

Authors:  Satdarshan P S Monga; Wendy M Mars; Peter Pediaditakis; Aaron Bell; Karen Mulé; William C Bowen; Xue Wang; Reza Zarnegar; George K Michalopoulos
Journal:  Cancer Res       Date:  2002-04-01       Impact factor: 12.701

7.  Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer.

Authors:  Elles M J Boon; Ronald van der Neut; Marc van de Wetering; Hans Clevers; Steven T Pals
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

8.  Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway.

Authors:  Jiong Deng; Weiya Xia; Stephanie A Miller; Yong Wen; Hong-Ying Wang; Mien-Chie Hung
Journal:  Mol Carcinog       Date:  2004-03       Impact factor: 4.784

9.  beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer.

Authors:  Jiong Deng; Stephanie A Miller; Hong-Ying Wang; Weiya Xia; Yong Wen; Binhua P Zhou; Yan Li; Shiaw-Yih Lin; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

10.  Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.

Authors:  Robert F Schwabe; David A Brenner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-07       Impact factor: 4.052

View more
  32 in total

1.  β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.

Authors:  Michael D Thompson; Akshata Moghe; Pamela Cornuet; Rebecca Marino; Jianmin Tian; Pengcheng Wang; Xiaochao Ma; Marc Abrams; Joseph Locker; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

2.  LGR4 protects hepatocytes from injury in mouse.

Authors:  Ziru Li; Shiying Liu; Jianing Lou; Michael Mulholland; Weizhen Zhang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-08       Impact factor: 4.052

3.  Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.

Authors:  Morgan E Preziosi; Sucha Singh; Erika V Valore; Grace Jung; Branimir Popovic; Minakshi Poddar; Shanmugam Nagarajan; Tomas Ganz; Satdarshan P Monga
Journal:  J Hepatol       Date:  2017-03-22       Impact factor: 25.083

4.  Role and Regulation of p65/β-Catenin Association During Liver Injury and Regeneration: A "Complex" Relationship.

Authors:  Kari Nejak-Bowen; Akshata Moghe; Pamela Cornuet; Morgan Preziosi; Shanmugam Nagarajan; Satdarshan P Monga
Journal:  Gene Expr       Date:  2017-04-28

Review 5.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.

Authors:  Satdarshan Pal Monga
Journal:  Gastroenterology       Date:  2015-03-05       Impact factor: 22.682

Review 6.  Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment.

Authors:  Amblessed E Onuma; Hongji Zhang; Hai Huang; Terence M Williams; Anne Noonan; Allan Tsung
Journal:  Gene Expr       Date:  2020-04-27

7.  Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3.

Authors:  Guo-Zhong Tao; Nadja Lehwald; Kyu Yun Jang; Joy Baek; Baohui Xu; M Bishr Omary; Karl G Sylvester
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

8.  Immunoexpression of canonical Wnt and NF-κB signaling pathways in the temporomandibular joint of arthritic rats.

Authors:  Luane Macêdo de Sousa; Joana Maria Dos Santos Alves; Conceição da Silva Martins; Karuza Maria Alves Pereira; Paula Goes; Delane Viana Gondim
Journal:  Inflamm Res       Date:  2019-08-01       Impact factor: 4.575

Review 9.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

10.  Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury.

Authors:  Harvinder Saggi; Dhiman Maitra; An Jiang; Rong Zhang; Pengcheng Wang; Pamela Cornuet; Sucha Singh; Joseph Locker; Xiaochao Ma; Harry Dailey; Marc Abrams; M Bishr Omary; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  J Hepatol       Date:  2018-10-01       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.